Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00740909 · ClinicalTrials.gov registry record · Phase 1

Cognitive Behavioral Therapy for Trichotillomania

A Phase 1 study of Trichotillomania, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 1
Development phase
38
Enrollment target
1
Study location

NCT00740909 is a Phase 1 study of Trichotillomania that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants, below the 67-participant average among 8 other Trichotillomania trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00740909, a Phase 1 study of Trichotillomania, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 1
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid affective symptoms, as well. The study will compare the efficacy of CBT with a minimal attention control (MAC)condition. We hypothesize that outcome at post-treatment, 3-month, and 6-month follow-up will be better for the CBT vs. MAC condition including higher responder rates and greater reduction in hair pulling severity.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2008-11
Est. Completion 2012-01
Phase Phase 1

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00740909

The ClinicalTrials.gov registry entry for NCT00740909 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 67-participant average among 8 other Trichotillomania trials with a reported enrollment target (43% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Trichotillomania appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT00740909 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00740909 about?

NCT00740909 is a clinical study titled "Cognitive Behavioral Therapy for Trichotillomania". This study aims to develop a comprehensive Cognitive Behavioral Therapy protocol for adult patients with Trichotillomania that emphasizes relapse prevention and that addresses comorbid affective symptoms, as well. The study will compare the efficacy of CBT with a minimal attention control (MAC)condi...

What is the current status of trial NCT00740909?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2008-11. Estimated completion is 2012-01.

What conditions does trial NCT00740909 study?

This clinical trial studies the following conditions: Trichotillomania.

What interventions are being tested in trial NCT00740909?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00740909?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00740909 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trichotillomania

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.